Skip to main content

and
  1. No Access

    Article

    Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase

    Hypoxia contributes to acquired drug resistance in various cancer cells. The underlying mechanism is cellular insensitivity regulated by hypoxia-inducible factors (HIF), which impairs drug uptake, transport, a...

    Sunny Guin, Qi Ma, Snehal Padhye, Yong-Qing Zhou in Cancer Chemotherapy and Pharmacology (2011)